LAM is caused by mutations in the tuberous sclerosis complex genes (TSC1 or TSC2), resulting in hyperactive mammalian Target of Rapamycin (mTOR) signaling. This evidence concerns the gene TSC1 and lymphangioleiomyomatosis.